 MALVERN, Pa., March 11, 2021 GLOBE NEWSWIRE -- Neuronetics, Inc. NASDAQ: STIM, a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that Gregory Harper, the companys Vice President, RD and Clinical, will retire effective March 31, 2021. 